COVID-19: Study shows five-day course of remdesivir works as well as 10-day one
Gilead has pledged to donate 1.5 million doses of remdesivir - or enough to treat… Read More
4 years ago
Gilead
Gilead ties up with generic drugmakers for COVID-19 drug supply
The pacts allow the companies - Jubilant Life Sciences, Cipla , Hetero Labs, Mylan NV… Read More
5 years ago
Japan approves drug as treatment for COVID-19
Japan reached the decision just three days after the U.S. drugmaker filed for fast-track approval… Read More
5 years ago
Who can make this American pharma’s coronavirus drug, licence free?
American pharmaceutical Gilead Sciences is in talks with chemical and drug makers to produce its… Read More
5 years ago
Pharma says this antiviral drug helped improve outcomes for COVID-19 patients
Gilead has defended prospects for remdesivir in helping fight the coronavirus pandemic against signs that… Read More
5 years ago
Medicare to cover expensive cancer cell therapies
The US Centers for Medicare and Medicaid Services (CMS) on Wednesday said it has finalized… Read More
5 years ago
Gilead’s new drug keeps 56 percent of lymphoma trial patients alive
More than half of trial patients with an advanced, aggressive form of blood cancer lived… Read More
7 years ago
Gilead challenges GSK with strong HIV drug data
SEATTLE: Gilead Sciences has thrown down a challenge to GlaxoSmithKline with good clinical trial results… Read More
8 years ago